Drug intelligence / Profile preview

multivirus-specific cytotoxic T lymphocytes

Development stage
Phase 1
Lead developer
Baylor College of Medicine
Modality
Adoptive Cell Transfer → Cell Therapies
Administration
Intravenous
01

Overview

Multivirus-specific cytotoxic T lymphocytes (mCTL) are a form of adoptive cell therapy in which T cells are collected from donors and expanded or engineered to recognize and target multiple viruses. These cells are typically used to treat or prevent viral infections in immunocompromised patients, such as those who have undergone hematopoietic stem cell transplantation. The mechanism of action involves the direct recognition and killing of virus-infected cells by the infused cytotoxic T lymphocytes that are specific for antigens from several viruses (e.g., CMV, EBV, adenovirus). This approach is being investigated primarily for its safety and efficacy in controlling viral reactivations post-transplant[1].

Other names
multivirus-specific cytotoxic T lymphocytesmulti-virus specific CTLmCTL cells

Beyond the preview

Go deeper on multivirus-specific cytotoxic T lymphocytes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on multivirus-specific cytotoxic T lymphocytes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call